Novartis AG (TSX:NVS)

Novartis AG Revenue

Novartis AG had revenue of $15.03B USD in the quarter ending September 30, 2026, with 4.67% growth. This brings the company's total for the last twelve months to $57.36B, up 1.76% year-over-year. In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth.

• Revenue (ttm): $57.36B
• Revenue Growth: +1.76%
• P/S Ratio: 5.25
• Revenue / Employee: $762.14K
• Employees: 75,267
• Market Cap: 427.93B CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Oncology 16.83B 29.7%
• Established Brands 12.46B 22.0%
• Immunology 10.29B 18.2%
• Cardiovascular, Renal And Metabolic 8.96B 15.8%
• Neuroscience 5.99B 10.6%
• Other 2.14B 3.8%

By Geography

Chart

• United States 23.33B 41.2%
• Europe 16.73B 29.5%
• Asia/Africa/Australasia 10.80B 19.1%
• Canada and Latin America 3.68B 6.5%
• Other 2.14B 3.8%

Fiscal year ended Dec 31, 2025 See the full Novartis AG breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	56.67B	4.95B	9.57%
Dec 31, 2024	51.72B	5.06B	10.85%
Dec 31, 2023	46.66B	-5.17B	-9.97%
Dec 31, 2022	51.83B	-1.05B	-1.98%
Dec 31, 2021	52.88B	2.98B	5.97%
Dec 31, 2020	49.90B	1.22B	2.51%
Dec 31, 2019	48.68B	2.58B	5.59%
Dec 31, 2018	46.10B	-4.04B	-8.05%
Dec 31, 2017	50.14B	699.00M	1.41%
Dec 31, 2016	49.44B	-951.00M	-1.89%
Dec 31, 2015	50.39B	-3.25B	-6.05%
Dec 31, 2014	53.63B	918.00M	1.74%
Dec 31, 2013	52.72B	745.00M	1.43%
Dec 31, 2012	51.97B	-7.40B	-12.47%
Dec 31, 2011	59.38B	7.81B	15.15%
Dec 31, 2010	51.56B	6.46B	14.32%
Dec 31, 2009	45.10B	2.52B	5.92%
Dec 31, 2008	42.58B	3.64B	9.34%
Dec 31, 2007	38.95B	3.84B	10.94%
Dec 31, 2006	35.11B	5.35B	17.99%
Dec 31, 2005	29.75B	-	-

Data Source: Fiscal.ai Last updated: Sep 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error